Comparison of Efficacy and Safety Between Low-Dose Ziprasidone in Combination With Sertraline and Ziprasidone Monotherapy for Treatment-Resistant Patients With Acute Exacerbation Schizophrenia: A Randomized Controlled Trial

Treatment-resistant schizophrenia (TRS) is a prevalent clinical problem with heterogeneous presentations. However, the clinical trial designs for new treatments are still lacking. This study aimed to assess the efficacy of ziprasidone plus sertraline in TRS patients as compared to ziprasidone monoth...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Hui, Xu, Jing, Lang, Xiaoe, Wu, Hanjing Emily, Xiu, Mei Hong, Zhang, Xiang Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086512/
https://www.ncbi.nlm.nih.gov/pubmed/35559243
http://dx.doi.org/10.3389/fphar.2022.863588

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086512/
https://www.ncbi.nlm.nih.gov/pubmed/35559243
http://dx.doi.org/10.3389/fphar.2022.863588

Ejemplares similares